Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates

NCT07703514 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: cH15/3
BIOLOGICAL: cH4/3
BIOLOGICAL: cH5/1N1
BIOLOGICAL: cH8/1N1
DRUG: Saline

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)